New developments in biomarkers for melanoma.

@article{Griewank2013NewDI,
  title={New developments in biomarkers for melanoma.},
  author={Klaus G Griewank and Selma Ugurel and Dirk Schadendorf and Annette Paschen},
  journal={Current opinion in oncology},
  year={2013},
  volume={25 2},
  pages={145-51}
}
PURPOSE OF REVIEW Therapy of malignant melanoma recently experienced remarkable advances with the introduction of two treatment regimens, gene mutation-based therapies with signaling pathway inhibitors (kinase inhibitors) and treatments with immune modulators. Both strategies prolong patients' survival but still have specific limitations, demanding the identification of additional genetic and immunological biomarkers as predictors of treatment response and prognosis. New developments in that… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…